Anticancer agent 330

Overview

Anticancer agent 330 is a semi-synthetic derivative of Salinomycin ( HY-15597 ) conjugated with triphenylphosphine, as well as an anticancer agent. Anticancer agent 330 induces G 0 /G 1 phase cell cycle arrest. Anticancer agent 330 reduces the production of ROS in cells. Anticancer agent 330 impairs mitochondrial integrity. Anticancer agent 330 promotes Autophagy . Anticancer agent 330 can be used in research related to ovarian cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Ovarian Cancer | Products > Disease Areas > Urogenital Cancer | Products > Signaling Pathways > Others | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Autophagy | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Drug Derivative | Products > Signaling Pathways > Reactive Oxygen Species (ROS) | Products > Signaling Pathways > Mitochondrial Metabolism

Product Information

• Catalog No.: HY-184338
• CAS No.: 3127025-65-1
• Molecular Formula: C63H87BrN3O10P
• Molecular Weight: 1157.26
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source